Home » Topics » BioWorld Science

BioWorld Science
RSS

Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM

July 13, 2018

Positive topline data presented from second pivotal phase III study of ZX-008 in Dravet Syndrome

July 13, 2018

Yale University develops novel SV2A radiotracer for PET imaging of synaptic density

July 13, 2018

Astellas' phase I study of ASP-1948 in advanced solid tumors enrolling patients

July 13, 2018

Beta Therapeutics divulges new heparanase inhibitors

July 13, 2018

GlaxoSmithKline, Astex Therapeutics describe NRF2 activators

July 13, 2018

CohBar starts first-in-human testing of CB-4211 for the treatment of NASH

July 13, 2018

Oral tecovirimat is a putative antiviral treatment of smallpox

July 13, 2018

Compass Therapeutics set to advance next-generation antibody-based therapeutics into clinic

July 13, 2018

Phase I trial of OncoNano's tumor imaging agent ONM-100 begins

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...